Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab : One-Year Outcome in the EPILOG Trial
Circulation - United States
doi 10.1161/01.cir.99.15.1951
Full Text
Open PDFAbstract
Available in full text
Date
April 20, 1999
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)